PDCD1 and neoplasm: To characterize changes in the tumor microenvironment associated with the antitumor activity of SPE and anti-PD1, we performed the phenotype of immune cells as CD8+ T-cells in a tumor microenvironment by flow cytometry to address whether SPE has reached this point.